Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00819884 · ClinicalTrials.gov registry record · Phase 1
To Evaluate 24-hr Glucose After OD vs BD AZD1656
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT00819884 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 36 participants.
The verdict
NCT00819884, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the 24-hour glucose profiles in diabetic patients treated with metformin following once daily and twice daily oral dosing
Interventions
- DRUG AZD1656
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00819884
The ClinicalTrials.gov registry entry for NCT00819884 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AZD1656 is the first listed.
NCT00819884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00819884 about?
NCT00819884 is a clinical study titled "To Evaluate 24-hr Glucose After OD vs BD AZD1656". The purpose of this study is to compare the 24-hour glucose profiles in diabetic patients treated with metformin following once daily and twice daily oral dosing
What is the current status of trial NCT00819884?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2009-01. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00819884?
The interventions under investigation include: AZD1656 (DRUG).
Who is sponsoring clinical trial NCT00819884?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.